Patents by Inventor ARJUN ARUMUGAM

ARJUN ARUMUGAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Matrix mesalamine extended release minitablets and its process thereof
    Patent number: 11975011
    Abstract: Compositions for development of matrix type extended release mesalamine minitablets without use of any modified release coating, comprising a) mesalamine or its prodrug or derivatives thereof having a weight percentage in a range of 65-85 weight percentage with respect to the composition; b) at least one intragranular excipient having a weight percentage in a range of 3.5-22.5 weight percentage with respect to the composition; c) at least one binder having a weight percentage in a range of 2-6.5 weight percent with respect to the composition; and d) at least one extra granular excipient having a weight percentage in a range of 2-5 weight percentage with respect to the composition such that largest dimension in the minitablet is range of 1.00 mm to 2.8 mm. In another aspect of the present disclosure provides for a process of preparation of composition.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: May 7, 2024
    Assignee: ATOZ PHARMACEUTICALS PVT LTD
    Inventors: Olaganathan Arumugam, Natarajan Venkatachalam, Arjun Arumugam
  • MATRIX MESALAMINE EXTENDED RELEASE MINITABLETS AND ITS PROCESS THEREOF
    Publication number: 20220133750
    Abstract: Compositions for development of matrix type extended release mesalamine minitablets without use of any modified release coating, comprising a) mesalamine or its prodrug or derivatives thereof having a weight percentage in a range of 65-85 weight percentage with respect to the composition; b) at least one intragranular excipient having a weight percentage in a range of 3.5-22.5 weight percentage with respect to the composition; c) at least one binder having a weight percentage in a range of 2-6.5 weight percent with respect to the composition; and d) at least one extra granular excipient having a weight percentage in a range of 2-5 weight percentage with respect to the composition such that largest dimension in the minitablet is range of 1.00 mm to 2.8 mm. In another aspect of the present disclosure provides for a process of preparation of composition.
    Type: Application
    Filed: November 2, 2021
    Publication date: May 5, 2022
    Inventors: OLAGANATHAN ARUMUGAM, NATARAJAN VENKATACHALAM, ARJUN ARUMUGAM